- 0
- 9
What changed
Each line against the same period a year earlier, as the company reported both in its latest filing. The math is under every line.
Latest quarter vs the same quarter a year earlier
10-Q filed 2026-10-21 ↗| Quarter ended | 2025-09-30 | 2026-09-30 | Change |
|---|---|---|---|
| Revenue(12,874 − 11,510) ÷ |11,510| × 100 = +11.8% ($ millions) | $11.5B | $12.9B | +11.8% |
| Operating income(4,459 − 3,248) ÷ |3,248| × 100 = +37.3% ($ millions) | $3.2B | $4.5B | +37.3% |
| Net income(3,664 − 2,547) ÷ |2,547| × 100 = +43.9% ($ millions) | $2.5B | $3.7B | +43.9% |
| Diluted earnings per share(0.87 − 0.59) ÷ |0.59| × 100 = +47.5% ($ a share) | $0.59 | $0.87 | +47.5% |
| Diluted share count (weighted)(4,195 − 4,340) ÷ |4,340| × 100 = −3.3% (millions of shares) | 4.34B | 4.20B | −3.3% |
| Research and development(1,033 − 854) ÷ |854| × 100 = +21.0% ($ millions) | $853.6M | $1.0B | +21.0% |
Latest fiscal year vs the year before
10-K filed 2026-01-23 ↗| Year ended | 2024-12-31 | 2025-12-31 | Change |
|---|---|---|---|
| Revenue(45,183 − 39,001) ÷ |39,001| × 100 = +15.9% ($ millions) | $39.0B | $45.2B | +15.9% |
| Operating income(13,327 − 10,418) ÷ |10,418| × 100 = +27.9% ($ millions) | $10.4B | $13.3B | +27.9% |
| Net income(10,981 − 8,712) ÷ |8,712| × 100 = +26.1% ($ millions) | $8.7B | $11.0B | +26.1% |
| Diluted earnings per share(2.53 − 1.98) ÷ |1.98| × 100 = +27.8% ($ a share) | $1.98 | $2.53 | +27.8% |
| Diluted share count (weighted)(4,344 − 4,393) ÷ |4,393| × 100 = −1.1% (millions of shares) | 4.39B | 4.34B | −1.1% |
| Research and development(3,391 − 2,925) ÷ |2,925| × 100 = +15.9% ($ millions) | $2.9B | $3.4B | +15.9% |
| Operating cash flow(10,149 − 7,361) ÷ |7,361| × 100 = +37.9% ($ millions) | $7.4B | $10.1B | +37.9% |
Metrics from the filings
Each value carries the period it covers and the form it was reported in.
| Metric | Value | Period end | Form |
|---|---|---|---|
| Revenue | $45.2B | 2025-12-31 | 10-K |
| Net income | $11.0B | 2025-12-31 | 10-K |
| Operating cash flow | $10.1B | 2025-12-31 | 10-K |
| Research and development | $3.4B | 2025-12-31 | 10-K |
| Total assets | $55.6B | 2025-12-31 | 10-K |
| Cash and cash equivalents | $9.0B | 2025-12-31 | 10-K |
| Shares outstanding | 4.11B | 2026-09-30 | 10-Q |
| Revenue | $12.9B | 2026-09-30 | 10-Q |
| Net income | $3.7B | 2026-09-30 | 10-Q |
| Revenue, prior year | $39.0B | 2024-12-31 | 10-K |
| Net income, prior year | $8.7B | 2024-12-31 | 10-K |
| Revenue, same quarter prior year | $11.5B | 2025-09-30 | 10-Q |
Videos on NFLX
No video on NFLX yet. Follow the company and you will hear when there is one.